KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $88.2 million.

  • GoodRx Holdings' Prepaid Assets rose 2219.33% to $88.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.2 million, marking a year-over-year increase of 2219.33%. This contributed to the annual value of $65.0 million for FY2024, which is 1421.97% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Prepaid Assets is $88.2 million, which was up 2219.33% from $80.3 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Prepaid Assets high stood at $94.0 million for Q2 2021, and its period low was $26.0 million during Q1 2022.
  • In the last 5 years, GoodRx Holdings' Prepaid Assets had a median value of $54.7 million in 2024 and averaged $54.6 million.
  • As far as peak fluctuations go, GoodRx Holdings' Prepaid Assets crashed by 5689.31% in 2022, and later surged by 8850.85% in 2024.
  • Quarter analysis of 5 years shows GoodRx Holdings' Prepaid Assets stood at $29.6 million in 2021, then skyrocketed by 53.11% to $45.4 million in 2022, then grew by 25.35% to $56.9 million in 2023, then rose by 14.22% to $65.0 million in 2024, then skyrocketed by 35.82% to $88.2 million in 2025.
  • Its Prepaid Assets was $88.2 million in Q3 2025, compared to $80.3 million in Q2 2025 and $79.1 million in Q1 2025.